<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01767038</url>
  </required_header>
  <id_info>
    <org_study_id>Creuzot-Garcher PHRC N 2010</org_study_id>
    <nct_id>NCT01767038</nct_id>
  </id_info>
  <brief_title>DOREFA (Retinal Detachment: Function and Anatomy)</brief_title>
  <acronym>DOREFA</acronym>
  <official_title>Study of Anatomical and Functional Recovery Following Retinal Detachment: Identify Correlations Between Visual Acuity and SD-OCT and Microperimetry Findings.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with retinal detachment do not always recover good visual function. Sometimes simple
      causes are responsible. Other causes can only be discovered thanks to high-resolution imaging
      provided by the latest generation of OCT.

      This study is possible thanks to surgical teams who have a strong recruitment potential, with
      the experience of a joint project in 2007-2008 (PHRC national - Etude DOREMY, Etude FRIENDS)
      to define more strict intervention criteria. The principal objective of this study is to
      better define with regard to time:

        -  The onset of surgically curable or transient macular affections, and losses in visual
           acuity that can be qualified as &quot;explained&quot;

        -  But above all to better understand the relationships between anatomical analyses
           obtained using OCT and autofluorescence and functional analysis using visual acuity and
           microperimetry.

        -  In the near future, two techniques (OCT and microperimetry) will certainly become
           essential tools in the evaluation of macular function. Better understanding of these
           relationships is the first necessary step in any study concerning the therapeutic
           prevention of retinal lesions related to retinal detachment: This study will make it
           possible to define criteria for the evaluation of anatomical and functional recovery,
           their relationship with each other and finally their evolution over time. This is an
           essential first phase before possible therapies can be evaluated.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2011</start_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Relationship between functional recovery and the aspect of external layers using Spectral Domain OCT.</measure>
    <time_frame>At six months after the intervention</time_frame>
    <description>Visual acuity, integrity of the IS/OS junction of the photoreceptors and the outer limiting membrane.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Peripheral deficits and quantification of hypoautofluorescent zones.</measure>
    <time_frame>At 3, 6 and 12 months after intervention</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Retinal Detachment</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>OCT Spectralis</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>microperimetry</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who have provided written informed consent

          -  Retinal detachment with pre-operative raised macula, re-attached during a surgical
             intervention with one month of follow-up

          -  Patients undergoing surgery as the first-line treatment (ab extern surgery or gas
             vitrectomy)

          -  Patients who accept to be followed for at least 12 months at the investigating center.

        Exclusion Criteria:

          -  Persons who are not registered with social security agency

          -  Macular affections pre-existent to the DR

          -  Retinal detachment requiring several interventions to obtain a reapplication

          -  Lazy eye with pre-operative

          -  Brightness of the circles not allowing the realization of the examinations
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Catherine CREUZOT-GARCHER</last_name>
    <phone>3 80 29 51 73</phone>
    <phone_ext>33</phone_ext>
    <email>catherine.creuzot-garcher@chu-dijon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Besançon</name>
      <address>
        <city>Besançon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernard Delbosc</last_name>
      <phone>3 81 66 84 76</phone>
      <phone_ext>33</phone_ext>
    </contact>
    <investigator>
      <last_name>Bernard Delbosc</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maher Saleh</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Bordeaux</name>
      <address>
        <city>Bordeaux</city>
        <zip>33000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-François Korobelnik</last_name>
      <email>jean-francois.korobelnik@chu-bordeaux.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-François Korobelnik</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie-Noëlle Delyfer</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Dijon</name>
      <address>
        <city>Dijon</city>
        <zip>21000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine CREUZOT-GARCHER</last_name>
      <phone>3 80 29 51 73</phone>
      <phone_ext>3</phone_ext>
      <email>catherine.creuzot-garcher@chu-dijon.fr</email>
    </contact>
    <investigator>
      <last_name>Catherine CREUZOT-GARCHER</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Grenoble</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe CHIQUET</last_name>
      <email>cchiquet@chu-grenoble.fr</email>
    </contact>
    <investigator>
      <last_name>Christophe CHIQUET</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Karine Palombi</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Nancy</name>
      <address>
        <city>Nancy</city>
        <zip>54035</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Paul Berrod</last_name>
      <email>jp.berrod@chu-nancy.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-Paul Berrod</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michel Weber</last_name>
      <email>michel.weber@chu-nantes.fr</email>
    </contact>
    <investigator>
      <last_name>Michel Weber</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Lariboisière</name>
      <address>
        <city>Paris</city>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ramin Tadayoni</last_name>
      <email>tadamin25@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Ramin Tadayoni</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Valérie KRIVOSIC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bénédicte DUPAS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pascale MASSIN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julien PEROZ</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sébastien BRUNEAU</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondation Ophtalmologique Adolphe de Rothschild</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yannick Lemer</last_name>
      <email>yannick.lemer@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Yannick Lemer</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Céline Faure</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Florence Metge</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Reims - Hôpital Robert Debré</name>
      <address>
        <city>Reims</city>
        <zip>51092</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carl Arndt</last_name>
      <phone>3 26 83 25 43</phone>
      <phone_ext>33</phone_ext>
      <email>carndt@chu-reims.fr</email>
    </contact>
    <investigator>
      <last_name>Carl Arndt</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Strasbourg - Hôpital Civil</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Gaucher</last_name>
      <email>david.gaucher@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>David Gaucher</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 10, 2013</study_first_submitted>
  <study_first_submitted_qc>January 10, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 11, 2013</study_first_posted>
  <last_update_submitted>January 10, 2013</last_update_submitted>
  <last_update_submitted_qc>January 10, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 11, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dissociative Disorders</mesh_term>
    <mesh_term>Retinal Detachment</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

